Determination of cut-off values for serum Leucine-Rich Alpha-2 Glycoprotein in the diagnosis of disease activity of Crohn's disease.

Determination of cut-off values for serum Leucine-Rich Alpha-2 Glycoprotein in the diagnosis of disease activity of Crohn's disease. - Determination of cut-off values for Serum LRG in the diagnosis of disease activity of Crohn's disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053299

Enrollment

500

Registered

2024-02-01

Start date

2024-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have Crohn's disease. Patients who have a history of outpatient visits or hospitalisation at the Nagoya University hospital, collaborating institutions or institutions that only provide existing samples and information. Patients who have experience of both LRG measurement and endoscopy.

Exclusion criteria

Exclusion criteria: Nanopia (Sekisi Medical) is not used in the LRG measurement kit. The interval between LRG measurement and endoscopy is longer than one month.

Design outcomes

Primary

Measure	Time frame
Cut-off value for Serum LRG in the diagnosis of disease activity of Crohn's disease	—

Secondary

Measure	Time frame
Correlation coefficient between LRG and each covariate, and regression coefficients of each covariate.	—

Countries

Japan

Contacts

Public ContactMuneyori Okita

Nagoya university graduate school of medicine. Department of Biostatistics.

okita.muneyori.e8@s.mail.nagoya-u.ac.jp052-744-2487

Outcome results